Atlas Trials

Nebulized Salbutamol Facilitate Management of Hyperkalemia Postreperfusion During Liver Transplantation

Clinical trial NCT05589441 · UNKNOWN

Trial details

NCT number
NCT05589441
Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Liver Transplantation
Start date
2022-10-28
Primary completion
2023-10-10
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.